Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,747 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Imaging biomarkers in the idiopathic inflammatory myopathies.
Zubair AS, Salam S, Dimachkie MM, Machado PM, Roy B. Zubair AS, et al. Among authors: roy b. Front Neurol. 2023 Apr 25;14:1146015. doi: 10.3389/fneur.2023.1146015. eCollection 2023. Front Neurol. 2023. PMID: 37181575 Free PMC article. Review.
Current status of clinical outcome measures in inclusion body myositis: a systematised review.
Roy B, Lucchini M, Lilleker JB, Goyal NA, Naddaf E, Adler B, Alfano LN, Malandraki GA, Focht Garand KL, Mochel D, Badrising U, Machado PM, Pagkatipunan R, Ramdharry G, Wang L, Funaro MC, Schmidt J, Kushlaf H, Schiopu E, Stipancic K, Goyal N, d'Alessandro M, Conticini E, Cruz-Coble B, Lloyd TE; International Myositis Assessment and Clinical Studies (IMACS) Inclusion Body Myositis Scientific Interest Group. Roy B, et al. Clin Exp Rheumatol. 2023 Mar;41(2):370-378. doi: 10.55563/clinexprheumatol/ifacv3. Epub 2023 Feb 3. Clin Exp Rheumatol. 2023. PMID: 36762744 Free article. Review.
Phenotypic spectrum of inclusion body myositis.
Roy B, Dimachkie MM, Naddaf E. Roy B, et al. Clin Exp Rheumatol. 2024 Feb;42(2):445-453. doi: 10.55563/clinexprheumatol/fhrx3q. Epub 2024 Feb 28. Clin Exp Rheumatol. 2024. PMID: 38436356 Free article. Review.
Neoadjuvant Chemotherapy Does Not Improve Survival in cT2N0M0 Gastric Adenocarcinoma Patients: A Multicenter Propensity Score Analysis.
Abboretti F, Lambert C, Schäfer M, Pereira B, Le Roy B, Mège D, Piessen G, Gagnière J, Gronnier C, Mantziari S; ADENOKGAST Study Group; AFC-French Association of Surgery. Abboretti F, et al. Among authors: le roy b. Ann Surg Oncol. 2024 May 18. doi: 10.1245/s10434-024-15418-2. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38762640
1,747 results